Biotech major Amgen Inc. AMGN will report third-quarter 2017 results on Oct 25 ... show that Amgen is likely to beat on earnings this quarter. This is because a stock needs to have both a positive Earnings ESPand a Zacks Rank #1 …
Range estimates are from $2.72 to $3.19 per share of AMGN stock. Street expectations imply a very modest increase in profits from the year ago period and mixed results over the last three quarters. Sequentially and compared to Q4, …
AMGN has reported positive but preannounced Repatha data, which disappointed investors. With the stock off to $168-169, I analyze it as not yet a good source of alpha. That's due to my review of the FOURIER outcomes study as good but …
This article is published in collaboration with Scutify, where you can find real-time markets and stock commentary from Robert Marcin, Cody Willard and others. Download the Scutify iOS App, the Scutify Android App or visit Scutify.com. …
Background - another pharma stock takes a dive In a surprising bit of stock market action, the iconic mega-cap Amgen (NASDAQ:AMGN) has collapsed 10% on what, superficially, was a perfectly acceptable Q3 earnings report. Of course, …